Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol.
Ontaneda D, Tallantyre EC, Raza PC, Planchon SM, Nakamura K, Miller D, Hersh C, Craner M, Bale C, Chaudhry B, Gunzler DD, Love TE, Gerry S, Coles A, Cohen JA, Evangelou N. Ontaneda D, et al. Among authors: bale c. Contemp Clin Trials. 2020 Aug;95:106009. doi: 10.1016/j.cct.2020.106009. Epub 2020 Apr 19. Contemp Clin Trials. 2020. PMID: 32320842
Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners.
Smith L, Elwick H, Mhizha-Murira JR, Topcu G, Bale C, Evangelou N, Timmons S, Leighton P, das Nair R; NEuRoMS collective. Smith L, et al. Among authors: bale c. Mult Scler Relat Disord. 2021 Apr;49:102563. doi: 10.1016/j.msard.2020.102563. Epub 2020 Oct 4. Mult Scler Relat Disord. 2021. PMID: 33677366 Free PMC article.
Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial.
Topcu G, Smith L, Mhizha-Murira JR, Goulden N, Hoare Z, Drummond A, Fitzsimmons D, Evangelou N, Schmierer K, Tallantyre EC, Leighton P, Allen-Philbey K, Stennett A, Bradley P, Bale C, Turton J, das Nair R; NEuRoMS Collective. Topcu G, et al. Among authors: bale c. Pilot Feasibility Stud. 2022 Jun 11;8(1):123. doi: 10.1186/s40814-022-01073-5. Pilot Feasibility Stud. 2022. PMID: 35690797 Free PMC article.
Providing Emotional Support During the Process of Multiple Sclerosis Diagnosis (PrEliMS): A Feasibility Randomised Controlled Trial.
das Nair R, Mhizha-Murira JR, Topcu G, Tindall T, Bale C, Moghaddam N, Scheffler-Ansari G, Drummond A, Fitzsimmons D, Evangelou N. das Nair R, et al. Among authors: bale c. Clin Rehabil. 2024 Nov;38(11):1506-1520. doi: 10.1177/02692155241284781. Epub 2024 Sep 25. Clin Rehabil. 2024. PMID: 39318328 Free PMC article. Clinical Trial.
C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation.
Heidenreich K, Goel D, Priyamvada PS, Kulkarni S, Chakurkar V, Khullar D, Singh R, Bale C, Zipfel PF. Heidenreich K, et al. Among authors: bale c. Front Nephrol. 2024 Oct 29;4:1460146. doi: 10.3389/fneph.2024.1460146. eCollection 2024. Front Nephrol. 2024. PMID: 39534179 Free PMC article. Review.
Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in Wales.
Burton JR, Halsby K, de la Fuente GS, Pearson-Stuttard J, Sloan R, Porter T, John G, Warburton A, Selby J, Povey G, Chowdhury R, Bale C, Davies M, Clifton-Brown E, Laing H. Burton JR, et al. Among authors: bale c. Pharmacoeconomics. 2024 Nov 11. doi: 10.1007/s40273-024-01445-0. Online ahead of print. Pharmacoeconomics. 2024. PMID: 39527398
174 results